[Clinical use of a new beta-mimetic agent: Ritodrine (Du 21220)]. 1972

P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007752 Obstetric Labor, Premature Onset of OBSTETRIC LABOR before term (TERM BIRTH) but usually after the FETUS has become viable. In humans, it occurs sometime during the 29th through 38th week of PREGNANCY. TOCOLYSIS inhibits premature labor and can prevent the BIRTH of premature infants (INFANT, PREMATURE). Preterm Labor,Labor, Premature,Premature Labor,Premature Obstetric Labor,Labor, Premature Obstetric,Labor, Preterm
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000033 Abortion, Threatened UTERINE BLEEDING from a GESTATION of less than 20 weeks without any CERVICAL DILATATION. It is characterized by vaginal bleeding, lower back discomfort, or midline pelvic cramping and a risk factor for MISCARRIAGE. Threatened Miscarriage,Miscarriage, Threatened,Threatened Abortion,Threatened Abortions,Threatened Miscarriages

Related Publications

P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
July 1969, The Journal of obstetrics and gynaecology of the British Commonwealth,
P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
January 1985, Clinical neuropharmacology,
P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
December 1972, Annali di ostetricia, ginecologia, medicina perinatale,
P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
August 1969, American journal of obstetrics and gynecology,
P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
January 1980, Rivista italiana di ginecologia,
P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
January 1977, La Tunisie medicale,
P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
January 1980, Akusherstvo i ginekologiia,
P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
January 1976, Arzneimittel-Forschung,
P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
January 1988, Tierarztliche Praxis,
P Buzzoni, and F Branconi, and P Gerli, and G Mello, and G Scarselli
May 1975, Revista espanola de anestesiologia y reanimacion,
Copied contents to your clipboard!